<DOC>
	<DOCNO>NCT01370317</DOCNO>
	<brief_summary>This study evaluate safety , tolerability , pharmacokinetics ( PK ) multiple dose treatment MK-1029 adult mild moderate persistent asthma .</brief_summary>
	<brief_title>Study To Evaluate Safety , Tolerability , Pharmacokinetics MK-1029 Participants With Mild Moderate Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>If female , must nonchildbearing potential Have history mild moderate asthma least 6 month Other asthma , general good health Able perform reproducible pulmonary function testing Is nonsmoker and/or use nicotine nicotinecontaining product least 12 month Have body mass index ( BMI ) ≥17 kg/m^2 , ≤35 kg/m^2 Demonstrate decrease absolute force expiratory volume 1 second ( FEV1 ) &gt; 20 % Screening Visit Baseline Visit Experience decrease AM PM peak expiratory flow ( PEF ) Stability Limit 2 consecutive day prior Baseline Visit Require use &gt; 8 inhalation per day shortacting beta2agonist meter dose inhaler ( MDI ) &gt; 2 nebulized treatment per day 2.5 mg albuterol , 2 consecutive day Screening Visit Baseline Visit Experience exacerbation define clinical deterioration asthma , judge clinical investigator , result emergency treatment , hospitalization due asthma , treatment additional , excluded medication ( shortacting beta agonist [ SABA ] ) time Screening Visit Baseline Visit Have hospitalize treatment asthma require oral corticosteroid treatment asthma within past 6 month , ever require ventilator support respiratory failure secondary asthma Require chronic use highdose inhaled corticosteroid Have diagnose chronic obstructive pulmonary disease ( COPD ) clinically relevant lung disease , asthma Have history illness might confound result study pose additional risk participant Have recent ( within 4 week first dose ) ongoing upper low respiratory tract infection Is nurse Have history significant multiple and/or severe allergy ( include latex allergy ) , anaphylactic reaction significant intolerability prescription nonprescription drug food</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>